Literature DB >> 17360728

An epidemiological study of pulmonary arterial hypertension.

A J Peacock1, N F Murphy, J J V McMurray, L Caballero, S Stewart.   

Abstract

All hospitalisations for pulmonary arterial hypertension (PAH) in the Scottish population were examined to determine the epidemiological features of PAH. These data were compared with expert data from the Scottish Pulmonary Vascular Unit (SPVU). Using the linked Scottish Morbidity Record scheme, data from all adults aged 16-65 yrs admitted with PAH (idiopathic PAH, pulmonary hypertension associated with congenital heart abnormalities and pulmonary hypertension associated with connective tissue disorders) during the period 1986-2001 were identified. These data were compared with the most recent data in the SPVU database (2005). Overall, 374 Scottish males and females aged 16-65 yrs were hospitalised with incident PAH during 1986-2001. The annual incidence of PAH was 7.1 cases per million population. On December 31, 2002, there were 165 surviving cases, giving a prevalence of PAH of 52 cases per million population. Data from the SPVU were available for 1997-2006. In 2005, the last year with a complete data set, the incidence of PAH was 7.6 cases per million population and the corresponding prevalence was 26 cases per million population. Hospitalisation data from the Scottish Morbidity Record scheme gave higher prevalences of pulmonary arterial hypertension than data from the expert centres (Scotland and France). The hospitalisation data may overestimate the true frequency of pulmonary arterial hypertension in the population, but it is also possible that the expert centres underestimate the true frequency.

Entities:  

Mesh:

Year:  2007        PMID: 17360728     DOI: 10.1183/09031936.00092306

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  209 in total

Review 1.  [Management of patients with pulmonary hypertension].

Authors:  B Preckel; S Eberl; J Fräßdorf; M W Hollmann
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

Review 2.  Pathobiology of pulmonary arterial hypertension and right ventricular failure.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Antonio Abbate; Harm J Bogaard; Mark R Nicolls
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

Review 3.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

4.  International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies.

Authors:  Jeffrey Link; Craig Glazer; Fernando Torres; Kelly Chin
Journal:  Chest       Date:  2010-08-19       Impact factor: 9.410

Review 5.  Definition, epidemiology and registries of pulmonary hypertension.

Authors:  R Awdish; H Cajigas
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

6.  Cardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension.

Authors:  Allan K N Alencar; Guilherme C Montes; Daniele G Costa; Luiza V P Mendes; Ananssa M S Silva; Sabrina T Martinez; Margarete M Trachez; Valéria do M N Cunha; Tadeu L Montagnoli; Aline G M Fraga; Hao Wang; Leanne Groban; Carlos A M Fraga; Roberto T Sudo; Gisele Zapata-Sudo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-08-10       Impact factor: 6.053

Review 7.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

8.  Clinical practice: pulmonary hypertension in children.

Authors:  Daniel De Wolf
Journal:  Eur J Pediatr       Date:  2009-01-16       Impact factor: 3.183

Review 9.  Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension.

Authors:  Shuyan Gu; Huimei Hu; Hengjin Dong
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

Review 10.  Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.

Authors:  Mark L Schiebler; Sanjeev Bhalla; James Runo; Nizar Jarjour; Alejandro Roldan; Naomi Chesler; Christopher J François
Journal:  J Thorac Imaging       Date:  2013-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.